Nepsis Inc’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Nepsis Inc's AMGN Position: Q2 2026 in Review
Nepsis Inc reduced its Amgen (AMGN) stake by 2.3% in Q2 2026, selling an estimated $374K and leaving 46,923 shares worth $17M. The position accounts for 5.76% of the portfolio, ranked #2.
Nepsis Inc first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $21.4M in Q1 2025. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Nepsis Inc held 46,923 shares of Amgen worth $17M as of Q2 2026.
- Nepsis Inc sold 1,094 Amgen shares in Q2 2026, an estimated $374K.
- Amgen made up 5.76% of Nepsis Inc's portfolio in Q2 2026, its #2 holding.
- Nepsis Inc first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
- Nepsis Inc's Amgen position peaked at $21.4M in Q1 2025.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Nepsis Inc's 13F filing for Q2 2026, filed 14 Jul 2026.